Anergis Company
Anergis, a clinical-stage biopharmaceutical company, discovers and develops allergy vaccines based on the technology of Contiguous Overlapping Peptides for ultra-fast desensitization. It offers vaccines against birch pollen, ragweed pollen, and house dust mite allergies.
Francois Spertini founded Anergis in 2001. Its headquarters in Lausanne in Switzerland.
Connections
Employee Number:
11-50
Headquarters:
Epalinges, Vaud, Switzerland, Europe
Founded Date:
2001-01-01
Industry:
Vaccines & Immunotherapy
Super Industry:
Biopharma & Life Science Tools
Phone Number:
0041-216519223
Investors:
BioMedPartners, BlueOcean Ventures, Esperante Ventures, Renaissance, Sunstone Life Science Ventures
Ipo Status:
private
City:
Epalinges
Region:
Vaud
Country:
Switzerland
Founders:
Francois Spertini